Q Azimi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND The aim of this study is to determine the level of serum cytokeratin19 fragment (cyfra21-1) in patients with benign or malignant pleural effusion and evaluation the sensitivity and specificity of this tumor marker. METHOD #ENTITYSTARTX00026; MATERIAL We prospectively evaluated 98 patients (39 malignant, 54 benign and the results were(More)
  • 1